Skip to main content

Table 3 Univariate Cox analysis of PFS, CSS and OS of MIBC patients

From: The prognostic value of routine preoperative blood parameters in muscle-invasive bladder cancer

Variate

PFS

CSS

OS

HR(95%CI)

P

HR(95%CI)

P

HR(95%CI)

P

Age

1.016 (0.990–1.042)

0.238

1.017 (0.991–1.044)

0.193

1.030 (1.005–1.056)

0.021*

BMI

0.979 (0.906–1.057)

0.581

0.974 (0.902–1.052)

0.499

0.994 (0.926–1.067)

0.864

Gender(male)

1.027 (0.550–1.918)

0.933

1.030 (0.552–1.923)

0.926

1.102 (0.606–2.002)

0.751

Smoking(yes)

0.892 (0.554–1.435)

0.637

0.953 (0.592–1.535)

0.844

0.929 (0.594–1.453)

0.746

Pathological grade

(high grade)

1.169 (0.648–2.111)

0.604

1.255 (0.694–2.272)

0.452

1.409 (0.794–2.498)

0.241

Pathological T stage

 T2

reference

reference

reference

 T3

3.185 (1.772–5.724)

< 0.001*

3.242 (1.802–5.833)

< 0.001*

2.926 (1.670–5.129)

< 0.001*

 T4

5.824 (3.266–10.385)

< 0.001*

5.841 (3.268–10.440)

< 0.001*

5.653 (3.265–9.786)

< 0.001*

Lymph node (positive)

4.559 (2.769–7.507)

< 0.001*

4.625 (2.799–7.643)

< 0.001*

4.183 (2.581–6.780)

< 0.001*

HGB ≥ 125

0.351 (0.211–0.583)

< 0.001*

0.355 (0.214–0.591)

< 0.001*

0.422 (0.265–0.671)

< 0.001*

NLR ≥ 2.42

1.569 (0.965–2.551)

0.069

1.603 (0.982–2.617)

0.059

1.653 (1.038–2.632)

0.034*

PLR ≥ 112

1.449 (0.896–2.345)

0.131

1.504 (0.928–2.436)

0.097

1.645 (1.041–2.600)

0.033*

  1. NLR Neutrophil-lymphocyte ratio, PLR Platelet-lymphocyte ratio, HGB Hemoglobin, BMI Body mass index, PFS Progression-free survival, CSS Cancer-specific survival, OS Overall survival, HR Hazard ratio, CI Confidence interval; * P < 0.05